
MHRA appoints three directors to its Board
pharmafile | July 31, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | DoH, MHRA
The Department of Health has announced that three new non-executive directors are joining the Medicines and Healthcare Products Regulatory Agency.
The three directors joining the MHRA are: Dame Valerie Beral, director of the Cancer Epidemiology Unit at the University of Oxford; Professor Alexander Markham, Professor of Medicine at the University of Leeds; and Professor David Webb (pictured), Christison Professor of Therapeutics and Clinical Pharmacology at the University of Edinburgh.
MHRA incorporates the Clinical Practice Research Datalink (CPRD), an e-health research service and the National Institute for Biological Standards and Control (NISBC), which assures the standards of biological medicines.
Lord Howe, health minister, said: “I am pleased to appoint Dame Valerie Beral, Professor Alexander Markham and Professor David Webb as non-executive directors of the MHRA. They bring a wealth of experience to our board and will play a key role in the leadership of the agency in its vital role, improving and protecting public health.”
Related Content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety
The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

IMed Consultancy releases white paper on Digital Mental Health Technologies
IMed Consultancy, a consultancy and service provider for the medical and health technology sector, has …

Dual immunotherapy for bowel cancer now available under NHS
Dual immunotherapy, a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), has been granted extension in …






